Procedures like gastric bypass or sleeve gastrectomy can lead to significant weight loss, but they come with risks and require a commitment to long-term lifestyle changes
TABLE 4 Sex-reported Odds ratio (ROR) for commonly reported adverse events with Semaglutide Note: a, number of cases with available
The BBB file was only opened in January 2025, which means the company operated for roughly eight years before having a BBB profile
Semaglutide is a GLP-1 receptor agonist, which means it works by helping to control blood sugar levels and curb appetite
The evolution of the GLP-1RA class to include an oral agent could facilitate the use of these agents earlier in the diabetes treatment cascade owing to wider acceptance from patients and healthcare professionals
Semaglutide injections are usually given in the abdomen, thigh or upper arm, each requiring specific needle considerations